Parsons MP, Hirasawa M. GIRK channel-mediated inhibition of melanin-concentrating hormone neurons by nociceptin/orphanin FQ. J Neurophysiol 105: 1179 -1184, 2011. First published December 29, 2010 doi:10.1152/jn.00791.2010.-Targeting the melanin-concentrating hormone (MCH) system has been suggested as a potential treatment for obesity, anxiety disorders, as well as addiction. Despite the therapeutic potential of MCH agonists and antagonists, the endogenous factors regulating MCH activity, in particular those implicated in anxiety and reward, are ill-defined. The present study investigated the cellular effects of nociceptin/orphanin FQ (N/OFQ), an endogenous opioid with anxiolytic and antireward properties, on MCH neurons. We found that N/OFQ induced a concentrationdependent reversible outward current in MCH neurons (EC 50 ϭ 50.7 nM), an effect that was blocked by the competitive antagonist of the nociceptin opioid peptide (NOP) receptor UFP-101. N/OFQ-induced outward currents persisted in TTX, reversed near the potassium equilibrium potential, and displayed inward rectification, suggesting direct postsynaptic potassium channel activation. Tertiapin-Q completely abolished the N/OFQ effect, whereas glibenclamide did not, implicating protein G-dependent inwardly rectifying potassium (GIRK) and not ATP-sensitive potassium (K ATP ) channels as the effector ion channel. The N/OFQ-induced outward current desensitized during repeated applications and occluded the inhibitory effect of dynorphin, suggesting that dynorphin and N/OFQ activate the same pathway. N/OFQ also reversibly inhibited voltage-gated calcium currents in MCH neurons. In conclusion, our study indicates N/OFQ as a robust endogenous regulator of MCH neurons, which may play a role in anxiety and drug addiction. electrophysiology; anxiety; addiction MELANIN-CONCENTRATING HORMONE (MCH) neurons are located exclusively within the lateral hypothalamus/perifornical area (LH/PFA) and zona incerta. Despite this restricted localization, MCH-containing fibers and MCH receptors (MCH1R) can be seen in widespread regions throughout the central nervous system (Bittencourt et al. 1992; Hervieu et al. 2000). Likely owing to its broad central distribution, MCH has been implicated in many physiological functions. For example, MCHdeficient mice are hypophagic, lean (Shimada et al. 1998) , hypermetabolic, and resistant to diet-induced obesity (Kokkotou et al. 2005). On the other hand, overexpression of this peptide generates susceptibility to obesity (Ludwig et al. 2001). MCH has also been linked to reward and addiction as well as stress and anxiety. MCH was recently shown to potentiate cocaine reward, whereas both cocaine-induced place preference and locomotor sensitization were diminished in mice lacking MCH1R (Chung et al. 2009 ). Furthermore, MCH has a stimulatory effect on the hypothalamic-pituitary-adrenal axis (Kennedy et al. 2003), and MCH antagonists act as potent anxiolytics when injected centrally (Borowsky et al. 2002) . As increased MCH activity is associated with obesity, drug addiction, and anxiety disorders, it is important to recognize the endogenous factors that regulate these neurons.
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Nociceptin/orphanin FQ (N/OFQ) is the most recently discovered endogenous opioid and binds to the nociceptin opioid peptide (NOP) receptor, which is expressed throughout the brain (Meunier et al. 1995; Reinscheid et al. 1995) . N/OFQ is a product of preproN/OFQ, which is structurally related to the other opioid precursors, in particular preprodynorphin. Furthermore, the NOP receptor shares ϳ60% homology with the classic -, ␦-, and -opioid receptors. Despite such similarities, the NOP receptor does not bind other endogenous opioids, and N/OFQ has no significant affinity for the -, ␦-, and -receptors (Meunier 1997) . However, unlike other opioid family members, N/OFQ has been referred to as the "antiopioid" of the brain as it can diminish the rewarding value of various drugs of abuse including cocaine, amphetamine, morphine, and ethanol (Sakoori and Murphy 2004; Kotlinska et al. 2003; Ciccocioppo et al. 2004) . N/OFQ peptide also plays a role in feeding (Stratford et al. 1997 ) and behavioral responses to stress (Koster et al. 1999) . Thus many physiological functions of N/OFQ overlap with those of the MCH system. NOP receptor expression has been demonstrated to exist within the LH/PFA and zona incerta (Neal Jr et al. 1999a) , and N/OFQ is coexpressed in orexin (hypocretin) neurons (Maolood and Meister 2010) , which are known to form synaptic appositions onto MCH neurons (van den Pol et al. 2004) , suggesting that N/OFQ is released onto MCH neurons. However, whether or how N/OFQ regulates MCH neurons is unknown. Therefore, the present study used conventional whole cell patch-clamp recordings from acute hypothalamic slices to investigate the cellular effect of N/OFQ on MCH neurons.
MATERIALS AND METHODS
All experiments followed the guidelines set by the Canadian Council on Animal Care and were approved by the Memorial University Institutional Animal Care Committee. Male Sprague-Dawley rats (60 -70 g) were obtained from the breeding colony at Memorial University.
Electrophysiology. Animals were deeply anesthetized with halothane and decapitated, and brains were quickly removed. Coronal hypothalamic slices (250 m) were sectioned in ice-cold artificial cerebrospinal fluid (ACSF) composed of (in mM): 126 NaCl, 2.5 KCl, 1.2 NaH 2 PO 4 , 1.2 MgCl 2 , 25 NaHCO 3 , 2 CaCl 2 , 10 glucose, pH 7.3-7.35. Following dissection, slices were incubated in ACSF at 32-35°C for 30 -45 min and then at room temperature until recording. ACSF was continuously bubbled with O 2 (95%)-CO 2 (5%).
Conventional whole cell patch-clamp recordings were performed on brain slices perfused with ACSF at 1.5-2 ml/min, 32-35°C, using a MultiClamp 700B amplifier and pClamp 9.2 (Molecular Devices, Sunnyvale, CA). The internal solution contained (in mM): 123 K gluconate, 2 MgCl 2 , 8 KCl, 0.2 EGTA, 10 HEPES, 4 Na 2 -ATP, 0.3 Na-GTP, pH 7.3-7.35. Biocytin (1-1.5 mg/ml) was included in the internal solution to label a subset of cells for post hoc immunohistochemical phenotyping, and these sections were processed to visualize biocytin, MCH, and orexin-A (Fig. 1, A and B ; orexin-A staining not shown). Targeted neurons were located in the LH, PFA, or zona incerta. On attaining whole cell access, the electrophysiological characteristics of each neuron were observed by a series of 300-ms hyperpolarizing (Ϫ200 and Ϫ100 pA) and depolarizing (100 and 200 pA) current injections in current-clamp mode. Cells that did not display voltage responses typical of MCH neurons were not used in the present study. These include spike adaptation on positive current injection and a lack of spontaneous action potentials, rebound, and H-currents (Fig. 1C) (Eggermann et al. 2003; Alberto et al. 2006) . During the course of the present experiments, 27 cells displaying characteristic MCH electrophysiological properties were successfully filled with biocytin and identified immunohistochemically. Of these 27 cells, 26 were MCH-immunopositive, suggesting that the detection of MCH neurons based on electrophysiological criteria is accurate (96%) in our hands. All cells displaying the aforementioned electrophysiological criteria were thus included in the present study. The 300-ms current injections described above were also performed every 30 s on cells recorded in current clamp to monitor input resistance as well as action potential responses to positive current injections. As MCH neurons rarely fire spontaneously in vitro (Eggermann et al. 2003) , all analyses of action potentials represent responses to the 100-pA current injection. All voltage-clamp experiments were performed at a holding potential of Ϫ70 mV with the exception of voltage ramps. To determine the effect of N/OFQ on current-voltage relationships, the membrane potential was ramped from Ϫ140 to Ϫ20 mV (600 ms) in the absence and presence of N/OFQ. To measure calcium currents, MCH neurons were first identified by their electrophysiological characteristics using the aforementioned internal and ACSF solutions. When an MCH neuron was obtained, the pipette was carefully removed from the cell, and the ACSF was switched to one containing (in mM): 100 NaCl, 40 TEA-Cl, 2.5 KCl, 2 MgCl 2 , 5 BaCl 2 , 10 HEPES, 10 glucose, 0.001 TTX. The same cell was then repatched using an internal solution containing (in mM): 120 CsCl, 1 MgCl 2 , 10 HEPES, 5 EGTA, 4 Mg-ATP, 0.5 Na 2 -GTP. In voltageclamp mode, voltage steps (100 ms) from Ϫ80 to 0 mV were applied every 5 s to activate voltage-dependent calcium channels. Cells in which a significant calcium current rundown was observed were not included for analysis.
Post hoc immunohistochemistry. Immunohistochemical phenotyping was performed as previously described (Alberto et al. 2006) . Briefly, immediately following recording, sections were fixed in 10% formalin for Ͼ48 h and then treated with a cocktail of goat antiorexin-A (1:2,000; Santa Cruz Biotechnology, Santa Cruz, CA) and rabbit anti-MCH (1:2,000; Phoenix Pharmaceuticals, Belmont, CA) antibodies for 3 days at 4°C, followed by Cy3-conjugated donkey anti-goat, Cy2-conjugated donkey anti-rabbit, and streptavidin-conjugated AMCA (1:500; Jackson ImmunoResearch, West Grove, PA). Sections were then visualized using a fluorescence microscope to detect MCH (Cy2), orexin-A (Cy3), and biocytin (AMCA).
Data analysis. Action potential frequency, membrane potential, and holding current were measured using Clampfit 9.2 (Molecular Devices). Data are expressed as means Ϯ SE. The statistical tests used included one-way ANOVA with Dunnett posttest for multiple-group comparisons and paired or unpaired Student's t-tests for two-group comparisons. A value of P Ͻ 0.05 was considered significant.
Drugs. Aliquots of drugs (1,000ϫ) were diluted with ACSF to their final concentration immediately before experimentation. TTX was obtained from Alomone Labs (Jerusalem, Israel), and picrotoxin (PTX) was obtained from Sigma-Aldrich (St. Louis, MO). N/OFQ(1-13)NH 2 , UFP-101, tertiapin-Q, and glibenclamide were obtained from Tocris Bioscience (Ellisville, MO) . N/OFQ(1-13)NH 2 is a bioactive metabolite of N/OFQ and was used in the present study as a potent NOP receptor agonist. N/OFQ(1-13)NH 2 is referred to as N/OFQ throughout RESULTS.
RESULTS
We first reasoned that if MCH neurons are influenced by N/OFQ, a response should be elicited by bath application of 1 M N/OFQ as this concentration was shown to induce a near-maximal inhibition of neighboring orexin neurons (Xie et al. 2008) . Using current-clamp recordings, we found that N/OFQ (1 M, 2-4 min) resulted in the reversible hyperpolarization of MCH neurons (21.3 Ϯ 2.2 mV, n ϭ 4; Fig. 2, A  and B) . This effect was accompanied by a significant decrease in input resistance (Fig. 2C) , suggestive of postsynaptic channel activation. On injection of 100-pA step currents, firing frequencies were significantly lower, and latencies to fire were significantly longer during N/OFQ application (Fig. 2, D and E) .
To investigate the mechanism of inhibition, the N/OFQ effect was examined in voltage-clamp mode at a holding potential of Ϫ70 mV. N/OFQ (2-4 min) induced a reversible outward current in all MCH neurons tested in a concentrationdependent manner (EC 50 ϭ 50.7 nM; Fig. 3B ). An amount of 0.3 M, which induced a robust effect, was used for the remainder of the study unless otherwise noted. The N/OFQinduced current was insensitive to TTX ( Fig. 3A ; n ϭ 4), suggesting a direct postsynaptic effect. Outward currents also persisted in the presence of the GABA A blocker PTX (50 M, n ϭ 8). When slices were preexposed (Ͼ5 min) to 1 M UFP-101 (Gompf et al. 2005 ), a peptide antagonist of the NOP receptor with a high affinity and selectivity over classic opioid receptors (Calo et al. 2005) , the effect of N/OFQ was significantly attenuated (n ϭ 4; Fig. 3, C and D) . These data suggest that N/OFQ acts postsynaptically at NOP receptors to hyperpolarize MCH neurons.
Additional studies were carried out to determine the effector channel(s) involved in N/OFQ-induced hyperpolarization. The voltage ramp protocol revealed an N/OFQ-induced steady-state current with inward rectification that reversed near the potassium equilibrium potential (Fig. 4, A and B) . These are the characteristics of inwardly rectifying potassium channels, i.e., ATP-sensitive potassium (K ATP ) or protein G-dependent inwardly rectifying potassium (GIRK) channels. Thus we decided to examine the effect of N/OFQ in the presence of glibenclamide (0.2 M) or tertiapin-Q (0.1 M), blockers of K ATP and GIRK channels, respectively. Pretreatment with glibenclamide (Ͼ5 min) at a concentration shown to be effective at blocking K ATP channels in the same hypothalamic preparation (Parsons and Hirasawa 2010) did not prevent the effect (n ϭ 3; Fig. 4, C and E) . However, in slices preexposed to tertiapin-Q (Ͼ5 min), the effect of N/OFQ on MCH neurons was significantly attenuated (n ϭ 7; Fig. 4, D and E) . We also found that N/OFQ (1 M, 30 s) reversibly inhibits voltagegated calcium currents in MCH neurons (Fig. 4, F and G) . Thus the effect of N/OFQ on MCH neurons involves the activation of GIRK, but not K ATP , channels as well as the inhibition of voltage-gated calcium channels.
Orexin neurons form direct appositions with MCH neurons (van den Pol et al. 2004 ) and coexpress dynorphin (Chou et al. 2001) and N/OFQ (Maolood and Meister 2010), suggesting that all of these peptides are likely released onto MCH neurons. It has been shown that orexin and dynorphin have direct excitatory and inhibitory effects on MCH neurons, respectively. Interestingly, the dynorphin effect desensitizes over repeated applications, whereas the orexin effect does not (Li and van den Pol 2006). Therefore, it was of interest to determine whether the inhibitory effect of N/OFQ also . Vertical lines denote responses to a series of current injections (Ϫ200 to ϩ200 pA in 100-pA increments, 300 ms each) applied every 30 s. Bottom: expanded traces are taken during the ϩ100-pA current injection from the corresponding time points at the top (a, b, and c). B: resting membrane potential is significantly hyperpolarized by N/OFQ (n ϭ 4). C: input resistance is significantly reduced by N/OFQ (n ϭ 4). D and E: in response to a ϩ100-pA current injection, action potential frequency (D) and latency to fire an action potential (E) decreases and increases, respectively, during N/OFQ application (n ϭ 4). *P Ͻ 0.05, **P Ͻ 0.01. CTL, control. desensitizes and whether the effects of dynorphin and N/OFQ share the same pathway. N/OFQ was applied three times to the same cell for 30 s each with a 10-to 15-min wash in between applications to allow each response to return to baseline (n ϭ 4). The amplitude of the outward currents in MCH neurons were attenuated with repeated applications to the same hypothalamic section (Fig. 5, A and  B) . Furthermore, when dynorphin (40 M) was tested in the presence of N/OFQ (1-10 M), the dynorphin effect was largely attenuated (Fig. 5, C-E ). These results demonstrate that the N/OFQ effect desensitizes and occludes the responsiveness of MCH neurons to dynorphin.
DISCUSSION
The present study demonstrates that N/OFQ can directly act as a powerful inhibitor of the MCH system by activating GIRK channels, which may be a cellular mechanism underlying the antireward and/or anxiolytic effects of N/OFQ. Previously reported cellular effects of N/OFQ in various brain regions include the activation of a barium-sensitive, inwardly rectifying potassium current (Connor et al. 1996; Vaughan and Christie 1996; Vaughan et al. 1997; Madamba et al. 1999) . The NOP receptor can couple to either GIRK (Ikeda et al. 1997) or K ATP currents (Armstead 1999) , both of which display inward rectification and barium sensitivity. The present study, by using specific blockers of these two channels, provides definitive evidence for the involvement of GIRK and not K ATP channels in the inhibitory effect of N/OFQ on MCH neurons. In addition, N/OFQ was found to inhibit voltage-gated calcium currents. Although we cannot rule out an effect on other ionic currents known to be modulated by N/OFQ such as BK and delayed rectifier currents (Chin et al. 2002; Qu et al. 2007 ), we conclude that the majority of the observed inhibition of MCH neurons results from modulation of GIRK and calcium channel activity.
Cotransmission from orexin to MCH neurons. Because of the widespread expression of N/OFQ in the brain (Neal Jr et al. The start of each application is denoted by an arrow. B: average peak outward currents for the 1st, 2nd, and 3rd N/OFQ applications (n ϭ 4). The magnitude of the N/OFQ-induced current decreases with repeated applications. C-E: dynorphin induces an outward current in MCH neurons (n ϭ 4) that is significantly occluded by prior induction of a maximal N/OFQ (1-10 M)-mediated outward current (n ϭ 6). **P Ͻ 0.01. showing a significant attenuation of the N/OFQ effect (n ϭ 8) on MCH neurons in slices exposed to TQ (n ϭ 7) but not Glib (n ϭ 3). F and G: N/OFQ (1 M) inhibits voltage-gated calcium currents in MCH neurons (n ϭ 6). **P Ͻ 0.01, ***P Ͻ 0.001. I Ca , calcium current. 1999b), the source(s) of N/OFQ release onto MCH neurons remains elusive. One likely candidate is from neighboring orexin neurons because these neurons coexpress N/OFQ (Maolood and Meister 2010) and form direct appositions with MCH neurons (van den Pol et al. 2004) . For simplicity, these neurons will be referred to as orexin neurons despite the fact that virtually all of them coexpress the endogenous -receptor agonist dynorphin (Chou et al. 2001) and N/OFQ. Orexin and dynorphin have direct excitatory and inhibitory effects on MCH neurons, respectively, which is a rare case where the postsynaptic cell exhibits opposing responses to two cotransmitted neuropeptides (Li and van den Pol 2006) . Interestingly, the excitatory effect of orexin does not desensitize as fast as the inhibitory effect of dynorphin. When both peptides are applied as a cocktail, the inhibitory effect prevails initially, but the cocktail becomes excitatory after repeated applications, reflecting the diminished responsiveness to dynorphin (Li and van den Pol 2006). In the present study, we demonstrate that N/OFQ also has an inhibitory but desensitizing effect. Therefore, it holds true that the nondesensitizing effect of orexin is likely to dominate following prolonged release of the peptide trio from orexin neurons (Li and van den Pol 2006). Furthermore, the inhibitory effect of N/OFQ occludes the effect of dynorphin, suggesting that these two opioids activate a common inhibitory pathway in MCH neurons. In all, the present study and that of Li and van den Pol (2006) demonstrate that the orexin-to-MCH synapse makes for an excellent model to study the complexities of peptide cotransmission.
Functional considerations. Ample evidence suggests that N/OFQ has a significant inhibitory influence on both anxietyand addiction-related behaviors. Deletion of the N/OFQ gene increases anxiety-like behaviors (Koster et al. 1999) , whereas activation of the NOP receptor has an anxiolytic effect (Gavioli et al. 2002; Griebel et al. 1999; Jenck et al. 1997; Jenck et al. 2000; Varty et al. 2005) . N/OFQ also abolishes the conditioned place preference and behavioral sensitization associated with a number of drugs of abuse (Sakoori and Murphy 2004; Kotlinska et al. 2003; Ciccocioppo et al. 2004 ). On the other hand, MCH promotes both anxiety and addiction (Borowsky et al. 2002; Chaki et al. 2005; Georgescu et al. 2005; Smith et al. 2006; Roy et al. 2006; Chung et al. 2009 ). Therefore, a robust inhibition of MCH neurons by N/OFQ demonstrated by the present data may represent a central mechanism by which N/OFQ attenuates anxiety and addiction.
In contrast, both MCH (Qu et al. 1996; Gomori et al. 2003 ) and N/OFQ (Polidori et al. 2000; Stratford et al. 1997 ) have been shown to induce food intake, which appears inconsistent with our finding. However, the orexigenic effect of N/OFQ may be site specific, as local injections into the ventromedial nucleus (Stratford et al. 1997) , arcuate nucleus (Polidori et al. 2000) , or the nucleus accumbens shell (Stratford et al. 1997) produces clear hyperphagia, whereas no significant effect on feeding is seen following N/OFQ injections into the paraventricular nucleus of the hypothalamus or the central nucleus of the amygdala (Polidori et al. 2000) . As the NOP receptor is commonly coupled to inhibitory G i/o proteins (Hawes et al. 1998) , it is likely that the hyperphagic effect of intraventricular N/OFQ (Polidori et al. 2000 ) is a summed product of its inhibitory actions on many cell groups and systems, which does not necessarily mimic the pattern of endogenous peptide release. As N/OFQ inhibits two major appetite-stimulating neurons of the LH/PFA, namely orexin (Xie et al. 2008) and MCH neurons (this study), this raises a possibility that the local action of N/OFQ within this area may not result in hyperphagia.
Conclusions. The present study demonstrates that N/OFQ is a potent inhibitor of MCH neurons. This inhibition results from a NOP-mediated activation of GIRK channels and inhibition of voltage-gated calcium currents. An N/OFQ-MCH interaction may play a role in the control of anxiety-like behaviors and an individual's vulnerability to addiction.
